TALIS BIOMEDICAL CORP (TLIS)
Institutional ownership reported to the SEC as of Q4 2024, across 16 quarters.
1
Reporting holders
$26
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Synergy Asset Management, LLC | $26 | 14 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2024 | 1 | $26 | 14 | 1 | 0 | 0 | 0.0% |
| Q3 2024 | 2 | $460.4K | 248,849 | 0 | 1 | 0 | 0.0% |
| Q2 2024 | 18 | $6.8M | 789,497 | 2 | 2 | 6 | 0.0% |
| Q1 2024 | 17 | $6.9M | 783,500 | 1 | 5 | 3 | 0.0% |
| Q4 2023 | 18 | $5.9M | 796,985 | 2 | 7 | 3 | 0.0% |
| Q3 2023 | 19 | $4.3M | 740,876 | 18 | 0 | 1 | 0.0% |
| Q2 2023 | 20 | $5.3M | 10,928,307 | 6 | 2 | 6 | 0.3% |
| Q1 2023 | 16 | $5.6M | 11,462,059 | 1 | 2 | 4 | 0.0% |
| Q4 2022 | 18 | $5.4M | 12,185,500 | 6 | 2 | 3 | 0.0% |
| Q3 2022 | 22 | $8.6M | 12,608,745 | 4 | 0 | 9 | 0.0% |
| Q2 2022 | 26 | $12.1M | 14,910,849 | 7 | 5 | 10 | 0.0% |
| Q1 2022 | 43 | $23.6M | 16,747,669 | 4 | 10 | 23 | 0.0% |
| Q4 2021 | 46 | $70.5M | 17,515,919 | 12 | 10 | 16 | 0.3% |
| Q3 2021 | 41 | $121.6M | 19,058,950 | 11 | 15 | 8 | 2.0% |
| Q2 2021 | 43 | $184.0M | 19,586,955 | 5 | 12 | 16 | 0.0% |
| Q1 2021 | 45 | $269.0M | 20,930,988 | 45 | 0 | 0 | 0.0% |